AGM 1470

Known as: AGM-1470 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2016
051019912016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
BACKGROUND Angiogenesis, the formation of new blood vessels, is essential for tumor growth. The inhibition of angiogenesis is… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Angiogenesis, the growth of new blood vessels, occurs normally in female reproductive organs. We tested the hypothesis that… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
BACKGROUND In previous animal studies, interleukin 12 (IL 12) was shown to inhibit the growth of a wide spectrum of tumors in… (More)
Is this relevant?
1995
1995
Hemangioma and other angiomatous diseases of childhood are common. Although most lesions are harmless and self-limiting, some are… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Recently, we reported the anti-angiogenic action along with anti-tumour activity of TNP-470 (AGM-1470). In this study, the effect… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1994
1994
Collagen-induced arthritis (CIA) is a T-cell-dependent rat model of rheumatoid arthritis (RA) that is induced by injection of… (More)
Is this relevant?
1994
1994
Glioblastoma is the most malignant primary brain tumor. Inhibition of angiogenesis is one potential strategy for treating this… (More)
Is this relevant?
1994
1994
AGM-1470 is a potent angiogenesis inhibitor that is very effective in inhibiting endothelial cell proliferation in both in vitro… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1993
1993
The effectiveness of AGM-1470, a potent, fungal-derived inhibitor of angiogenesis, in suppressing the neovascularization and… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
The anti-angiogenic activity of AGM-1470, a new synthetic analog of fumagillin isolated from Aspergillus fumigatus, was… (More)
Is this relevant?